Indaptus Therapeutics, Inc
Price
FilingsNewest: 8-K, Material agreementSep 30 →InsidersNo open-market buys or sales.→HoldersGeode 0.0%Jane Street 0.0%Vanguard 0.0%→Financing →PeersClosest companies: CLDI, CMPX, AKTX→
From the filings
Figures
- Net income
- −$15.4Mlast 12 months
- Operating cash flow
- −$16.8Mlast 12 months
- Cash and equivalents
- $7.6Mat the last balance sheet
- Shares outstanding
- 133.2M shareson issue